TB patients with known positive HIV status and TB patients living in HIV-prevalent settings
should receive at least 6 months of a rifampicin-containing treatment regimen. The
optimal dosing frequency is daily during the intensive and continuation phases.
Guideline Citation
Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection
Recommendations for a public health approach - Second edition. Geneva: World Health Organization; 2016.
Recommendations for a public health approach - Second edition. Geneva: World Health Organization; 2016.
Grade Certainty of evidence
Grade Strength
Grade Certainty of evidence label
Recommendation Direction